NO309093B1 - Kjemiske forbindelser og anvendelse derav - Google Patents

Kjemiske forbindelser og anvendelse derav Download PDF

Info

Publication number
NO309093B1
NO309093B1 NO943002A NO943002A NO309093B1 NO 309093 B1 NO309093 B1 NO 309093B1 NO 943002 A NO943002 A NO 943002A NO 943002 A NO943002 A NO 943002A NO 309093 B1 NO309093 B1 NO 309093B1
Authority
NO
Norway
Prior art keywords
mmol
formula
ethyl acetate
compound
hydroxy
Prior art date
Application number
NO943002A
Other languages
English (en)
Norwegian (no)
Other versions
NO943002D0 (no
NO943002L (no
Inventor
Jerzy Golik
John F Kadow
Murray Arthur Kaplan
Wen-Sen Li
Robert Kevin Perrone
John K Thottathil
Dolatrai Vyas
Mark D Wittman
Henry Wong
John J Wright
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of NO943002D0 publication Critical patent/NO943002D0/no
Publication of NO943002L publication Critical patent/NO943002L/no
Publication of NO309093B1 publication Critical patent/NO309093B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic System
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
    • C07F9/6551—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a four-membered ring
    • C07F9/65512—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a four-membered ring condensed with carbocyclic rings or carbocyclic ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65586—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system at least one of the hetero rings does not contain nitrogen as ring hetero atom
    • H—ELECTRICITY
    • H01—ELECTRIC ELEMENTS
    • H01L—SEMICONDUCTOR DEVICES NOT COVERED BY CLASS H10
    • H01L21/00—Processes or apparatus adapted for the manufacture or treatment of semiconductor or solid state devices or of parts thereof
    • H01L21/02—Manufacture or treatment of semiconductor devices or of parts thereof
    • H01L21/04—Manufacture or treatment of semiconductor devices or of parts thereof the devices having at least one potential-jump barrier or surface barrier, e.g. PN junction, depletion layer or carrier concentration layer
    • H01L21/48—Manufacture or treatment of parts, e.g. containers, prior to assembly of the devices, using processes not provided for in a single one of the subgroups H01L21/06 - H01L21/326
    • H01L21/4814—Conductive parts
    • H01L21/4821—Flat leads, e.g. lead frames with or without insulating supports
    • H01L21/4839—Assembly of a flat lead with an insulating support, e.g. for TAB
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/582—Recycling of unreacted starting or intermediate materials
NO943002A 1993-08-17 1994-08-15 Kjemiske forbindelser og anvendelse derav NO309093B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10801593A 1993-08-17 1993-08-17
US15484093A 1993-11-24 1993-11-24
US24511994A 1994-05-17 1994-05-17

Publications (3)

Publication Number Publication Date
NO943002D0 NO943002D0 (no) 1994-08-15
NO943002L NO943002L (no) 1995-02-20
NO309093B1 true NO309093B1 (no) 2000-12-11

Family

ID=27380403

Family Applications (1)

Application Number Title Priority Date Filing Date
NO943002A NO309093B1 (no) 1993-08-17 1994-08-15 Kjemiske forbindelser og anvendelse derav

Country Status (20)

Country Link
EP (1) EP0639577B1 (fr)
JP (1) JP3062986B2 (fr)
KR (1) KR100249306B1 (fr)
CN (2) CN1051315C (fr)
AT (1) ATE217629T1 (fr)
AU (2) AU694941B2 (fr)
CA (1) CA2129288C (fr)
CY (1) CY2295B1 (fr)
CZ (1) CZ194794A3 (fr)
DE (1) DE69430611T2 (fr)
DK (1) DK0639577T3 (fr)
ES (1) ES2176212T3 (fr)
FI (1) FI113271B (fr)
HU (1) HUT67742A (fr)
IL (2) IL110660A0 (fr)
NO (1) NO309093B1 (fr)
NZ (1) NZ264240A (fr)
PL (1) PL179636B1 (fr)
PT (1) PT639577E (fr)
RU (1) RU2128661C1 (fr)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6515009B1 (en) 1991-09-27 2003-02-04 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US5811447A (en) 1993-01-28 1998-09-22 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
FR2698871B1 (fr) 1992-12-09 1995-02-24 Rhone Poulenc Rorer Sa Nouveau taxoïdes, leur préparation et les compositions pharmaceutiques qui les contiennent.
CA2111527C (fr) * 1992-12-24 2000-07-18 Jerzy Golik Phosphonooxymethylethers de derives du taxane
US5981568A (en) 1993-01-28 1999-11-09 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US6491938B2 (en) 1993-05-13 2002-12-10 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US6232477B1 (en) 1996-03-25 2001-05-15 Aventis Pharma S.A. Methods of preparing new taxoids and pharmaceutical compositions containing them
US6040466A (en) * 1996-03-25 2000-03-21 Rhone Poulenc Rorer Sa Taxoids, their preparation and pharmaceutical compositions containing them
US6593482B2 (en) 1993-02-01 2003-07-15 Aventis Pharma S.A. Methods for preparing new taxoids and pharmaceutical compositions containing them
FR2732340B1 (fr) * 1995-03-27 1997-04-30 Rhone Poulenc Rorer Sa Nouveaux taxoides, leur preparation et les compositions pharmaceutiques qui les contiennent
US5677470A (en) * 1994-06-28 1997-10-14 Tanabe Seiyaku Co., Ltd. Baccatin derivatives and processes for preparing the same
US6458976B1 (en) 1994-10-28 2002-10-01 The Research Foundation Of State University Of New York Taxoid anti-tumor agents, pharmaceutical compositions, and treatment methods
AU4133096A (en) * 1994-10-28 1996-05-23 Research Foundation Of The State University Of New York, The Taxoid derivatives, their preparation and their use as antitumor agents
US6500858B2 (en) 1994-10-28 2002-12-31 The Research Foundation Of The State University Of New York Taxoid anti-tumor agents and pharmaceutical compositions thereof
CA2162759A1 (fr) * 1994-11-17 1996-05-18 Kenji Tsujihara Derives de la baccatine et methodes de preparation
MA23823A1 (fr) * 1995-03-27 1996-10-01 Aventis Pharma Sa Nouveaux taxoides, leur preparation et les compositions qui les contiennent
US5847170A (en) * 1995-03-27 1998-12-08 Rhone-Poulenc Rorer, S.A. Taxoids, their preparation and pharmaceutical compositions containing them
US6372780B2 (en) 1995-03-27 2002-04-16 Aventis Pharma S.A. Methods of treating cell lines expressing multidrug resistance P-glycoprotein
TW354293B (en) * 1995-06-06 1999-03-11 Bristol Myers Squibb Co Prodrugs of paclitaxel derivatives
US6245805B1 (en) * 1995-10-26 2001-06-12 Baker Norton Pharmaceuticals, Inc. Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents
EP0822815A4 (fr) * 1996-01-31 1998-04-01 Bristol Myers Squibb Co Procede permettant de rendre actifs du point de vue pharmaceutique des taxanes assimilables par voie orale
ES2226120T3 (es) 1997-03-31 2005-03-16 Boston Scientific Limited Inhibidor terapeutico de celulas del musculo liso vascular.
US6156789A (en) * 1998-03-17 2000-12-05 Rhone-Poulenc Rorer S.A. Method for treating abnormal cell proliferation in the brain
US6204257B1 (en) * 1998-08-07 2001-03-20 Universtiy Of Kansas Water soluble prodrugs of hindered alcohols
EP1020188A1 (fr) * 1999-01-13 2000-07-19 Aventis Pharma S.A. Nouvelle utilisation de dérivés taxoides
US6362172B2 (en) * 2000-01-20 2002-03-26 Bristol-Myers Squibb Company Water soluble prodrugs of azole compounds
US6780879B2 (en) 2000-02-02 2004-08-24 Fsu Research Foundation, Inc. C7 carbonate substituted taxanes
CN1186340C (zh) 2000-02-02 2005-01-26 佛罗里达州立大学研究基金有限公司 用作抗肿瘤剂的c10碳酸酯取代的紫杉烷
US6649632B2 (en) 2000-02-02 2003-11-18 Fsu Research Foundation, Inc. C10 ester substituted taxanes
DE60131537T2 (de) 2000-06-22 2008-10-23 Nitromed, Inc., Lexington Nitrosierte und nitrosylierte taxane, zubereitungen und methoden der verwendung
US6448401B1 (en) 2000-11-20 2002-09-10 Bristol-Myers Squibb Company Process for water soluble azole compounds
WO2003087078A1 (fr) 2002-04-05 2003-10-23 Natural Pharmaceuticals, Inc. Acylation selective de groupes hydroxyle secondaires
US7390898B2 (en) * 2002-08-02 2008-06-24 Immunogen Inc. Cytotoxic agents containing novel potent taxanes and their therapeutic use
CN100522955C (zh) * 2002-08-02 2009-08-05 伊缪诺金公司 含有新型强效紫杉烷的细胞毒性剂及其治疗用途
US8703982B2 (en) 2003-03-17 2014-04-22 Phyton Holdings Llc Purification of taxanes
PE20050693A1 (es) 2004-02-13 2005-09-27 Univ Florida State Res Found Taxanos sustituidos con esteres de ciclopentilo en c10
CA2718567A1 (fr) 2008-03-31 2009-12-03 Florida State University Research Foundation, Inc. Taxanes substitues par un ester ethylique en c(10) et un ester cyclopropylique en c(10)
EP2719708B1 (fr) 2009-11-13 2017-10-25 Daiichi Sankyo Europe GmbH Matériau et procédés de traitement ou de prévention de maladies associées à des HER-3
AU2011286407A1 (en) 2010-08-06 2013-02-21 Amgen Use of HER3 binding agents in prostate treatment
CA2846572C (fr) 2011-08-25 2019-12-31 Bonac Corporation Composes glycosides, methodes de production des composes et production d'acides nucleiques a l'aide desdits composes
CN104650012A (zh) 2013-11-22 2015-05-27 天士力控股集团有限公司 一种紫杉烷类化合物
JP6481022B2 (ja) * 2015-04-02 2019-03-13 株式会社ボナック 配糖体化合物の製造方法
CN110862410A (zh) * 2018-08-27 2020-03-06 深圳福山生物科技有限公司 三氟甲基硒化合物及其用途
US11976034B2 (en) 2019-06-12 2024-05-07 Nouryon Chemicals International B.V. Process for the production of diacyl peroxides
BR112021024870A2 (pt) * 2019-06-12 2022-01-18 Nouryon Chemicals Int Bv Método para isolar ácido carboxílico de uma corrente lateral aquosa de um processo de produção de peróxido orgânico
JP7336541B2 (ja) 2019-06-12 2023-08-31 ヌーリオン ケミカルズ インターナショナル ベスローテン フェノーツハップ 過酸化ジアシルを生成するためのプロセス

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2678930B1 (fr) * 1991-07-10 1995-01-13 Rhone Poulenc Rorer Sa Procede de preparation de derives de la baccatine iii et de la desacetyl-10 baccatine iii.
FR2679230B1 (fr) * 1991-07-16 1993-11-19 Rhone Poulenc Rorer Sa Nouveaux derives d'analogues du taxol, leur preparation et les compositions qui les contiennent.
US5229526A (en) * 1991-09-23 1993-07-20 Florida State University Metal alkoxides
US5272171A (en) * 1992-02-13 1993-12-21 Bristol-Myers Squibb Company Phosphonooxy and carbonate derivatives of taxol
CA2111527C (fr) * 1992-12-24 2000-07-18 Jerzy Golik Phosphonooxymethylethers de derives du taxane

Also Published As

Publication number Publication date
RU94029662A (ru) 1996-07-10
JPH07149779A (ja) 1995-06-13
FI943749A0 (fi) 1994-08-15
DE69430611T2 (de) 2002-12-19
CN1237580A (zh) 1999-12-08
AU706511B2 (en) 1999-06-17
CY2295B1 (en) 2003-07-04
EP0639577A1 (fr) 1995-02-22
FI943749A (fi) 1995-02-18
PT639577E (pt) 2002-10-31
KR100249306B1 (ko) 2000-04-01
KR950005834A (ko) 1995-03-20
HU9402342D0 (en) 1994-10-28
RU2128661C1 (ru) 1999-04-10
CZ194794A3 (en) 1995-08-16
CA2129288C (fr) 2000-05-16
PL304649A1 (en) 1995-02-20
DE69430611D1 (de) 2002-06-20
AU9135698A (en) 1999-01-14
NZ264240A (en) 1997-10-24
CN1051315C (zh) 2000-04-12
PL179636B1 (pl) 2000-10-31
AU694941B2 (en) 1998-08-06
NO943002D0 (no) 1994-08-15
FI113271B (fi) 2004-03-31
CN1100771C (zh) 2003-02-05
DK0639577T3 (da) 2002-08-19
ATE217629T1 (de) 2002-06-15
ES2176212T3 (es) 2002-12-01
CN1111637A (zh) 1995-11-15
HUT67742A (en) 1995-04-28
AU7026794A (en) 1995-03-02
EP0639577B1 (fr) 2002-05-15
JP3062986B2 (ja) 2000-07-12
NO943002L (no) 1995-02-20
CA2129288A1 (fr) 1995-02-18
IL128425A0 (en) 2000-01-31
IL110660A0 (en) 1994-11-11

Similar Documents

Publication Publication Date Title
NO309093B1 (no) Kjemiske forbindelser og anvendelse derav
US5646176A (en) Phosphonooxymethyl ethers of taxane derivatives
EP0604910B1 (fr) Ethers phosphono-oxyméthyliques de dérivés du taxane
EP0590267B1 (fr) Désoxy-taxols
FI109795B (fi) Menetelmä terapeuttisesti käyttökelpoisten 6,7-modifioitujen paklitakseleiden valmistamiseksi
EP0694539B1 (fr) 7-O-éthers de dérivés de taxane
EP0747385B1 (fr) Promédicaments de dérivés du paclitaxel
FI110942B (fi) Menetelmä terapeuttisesti käyttökelpoisten fluoritaksolien valmistamiseksi
DE60111614T2 (de) Taxan-derivate für die behandlung von krebs
RU2136673C1 (ru) Фосфонооксиметиловые эфиры таксановых производных, промежуточные соединения, противоопухолевая фармацевтическая композиция, способ ингибирования роста опухоли у млекопитающих
EP1011329B1 (fr) Paclitaxels 7-methylthiooxomethyle et 7-methylthiodioxomethyle